V arious experimental approaches have indicated that the apelin-APJ pathway is a potent regulator of both cardiac and vascular functions. [1] [2] [3] [4] The apelin (also known as APLN) ligand is translated as a 77-amino-acid pre-pro peptide and cleaved to shorter peptides that bind the G-protein-coupled receptor APJ (also known as AGTRL1/APLNR). 5, 6 Apelin is expressed primarily in the endothelium and acts both locally and in a paracrine manner to activate APJ. 7, 8 In the vasculature, studies support a vasodepressor role in both the arterial and venous circulation and suggest that these effects are mediated at least in part by nitric oxide. 2, [9] [10] [11] [12] Direct inotropic effects have also been demonstrated in isolated rodent hearts and cardiomyocytes. 1, 13 signaling regulates migration of myocardial progenitors to the midline from the anterior lateral plate mesoderm, and that disruption of this pathway leads to defective migration, loss of critical inductive differentiation signals, and failure of myocardial progenitor cell development. [17] [18] [19] Despite these studies in model organisms, null mutations in the Apln and Apj locus have failed to provide definitive evidence for a role in higher vertebrate cardiovascular development. 1, 10, 20, 21 Here, we characterize the cardiovascular developmental phenotype of the Apj null mice. Homozygous targeted animals failed to be delivered in a mendelian pattern, and embryos exhibited a spectrum of cardiac and vascular developmental defects. Moreover, we describe a novel, noncanonical signaling cascade by which apelin-APJ signaling, via involvement of Gα13, histone deacetylase (HDAC) 4, and HDAC5, activates the myocyte enhancer factor 2 (MEF2) transcription factors, which have critical roles in cardiovascular development. [22] [23] [24] Our results implicate a key role for apelin-APJ signaling as an important regulatory switch that controls the activation of MEF2 transcription factors in cardiovascular development.
Methods
An expanded Methods section is available in the Online Data Supplement.
Mice
All animal experiments were conducted with approval of the Yale University and Stanford University Institutional Animal Care and Use Committees. The global Apj −/− mice were previously described. 21 In brief, a single targeting construct was made containing the C57BL/6 Apj homology region, 3 LoxP sites, and the neomycin and diphtheria toxin genes. The construct was transfected into B6-3 embryonic stem cells and targeted embryonic stem cell clones transfected with pB-SCre, and resulting clones found to have deleted both the neo and Apj genes were injected into C57BL/6J-Tyrc-2J blastocysts to establish the targeted allele fully in the C57BL/6 background.
Cell Culture and Transfection
Mouse heart ECs were isolated by digesting whole hearts with collagenase (2 mg/mL) with gentle agitation for 45 minutes at 37°C. The cell suspension was triturated 12 times, filtered through 70-μm cell strainers, and then centrifuged at 400g for 5 minutes at 4°C. Cells were resuspended in 2 mL cold PBS with 0.1% BSA, and the cell suspension was incubated with Dynabeads (110.35-mouse, Invitrogen) coated with purified antibody to CD31 (553370 [mouse], 5 μL per 50 μL bead suspension, BD Pharmingen). We performed a second sorting step to ensure the purity of the ECs. Human umbilical vein ECs (HUVECs; Yale VBT Core) and COS7 cells (Lonza) were cultured at 37°C in a 5% CO 2 incubator. For HUVECs, growth medium was EGM-2 (Lonza) containing 2% fetal bovine serum. DMEM (Gibco) with 10% fetal bovine serum was used for COS7. For experimental treatments, HUVECs (passages 3-7) were grown to 70% to 90% confluence. Transient transfections of plasmids were performed with Fugene HD (Promega) using the manufacturer's protocol. For gene silencing, small interfering RNAs (Stealth siRNA, Invitrogen) were transfected with RNAiMAX (Invitrogen) using the manufacturer's protocols.
Statistical Analysis
All in vitro experiments (chromatin immunoprecipitation assays, immunoprecipitations, Western blots, and quantitative polymerase chain reaction [qPCR] assays) are representative of 3 independent experiments. Results are reported as mean±SEM. An unpaired Student t test or 1-way ANOVA test was used as appropriate to determine statistical significance. Post hoc analysis was performed with the Bonferroni method. Values of P<0.05 were considered significant.
Results

Apj Deficiency Results in Incomplete Embryonic Lethality
Our previous findings, as well as Apj knockout (Apj −/− ) mice generated by other groups, demonstrate a significantly decreased number of Apj −/− mice that are born (although not discussed, we found the offspring genotype ratio of Ishida et al 10 to be statistically significant by χ 2 test with P<0.03). 20, 21 Heterozygous Apj +/− animals were fully viable and fertile. Mating of Apj +/− mice resulted in a lower-than-expected number of Apj −/− mice at the time of weaning (238 offspring studied, with 139 heterozygotes, 77 wild type, and 22 null mutants), reflecting statistically significant fewer Apj −/− mice (χ 2 , P=1.05×10 −7 ) . Further embryonic evaluation demonstrated that lethality began at embryonic day (E) 10.5 and continued through to E12.5 (Table) . Moreover, >20% of Apj −/− pups died immediately after birth. Based on a 25% expected homozygous null mice, we saw only 9.2% a live Apj −/− mice at the time of weaning. We did not observe any embryonic or postnatal death in the wild-type or the heterozygous mice.
Apj −/− Embryos Have Vascular Defects
The Apj −/− embryos showed a spectrum of vascular deficits at early embryonic stages. Roughly 22% (7 of 32) of the surviving Apj −/− embryos at E10.5 had impaired maturation of the yolk sac vasculature, with a paucity of developed vascular structures ( Figure 1A) . Moreover, the same percentage (7 of 32) had anterior cardinal veins and dorsal aorta that either were lacking or were small and aberrantly located ( Figure 1B ). Staining of whole embryos (E9.5) with an anti-CD31 antibody suggested that ECs were present at a comparable level but contributed to vessels that were not formed appropriately (Online Figure I) .
We further evaluated those embryos that survived to later stages (E12.5-E15.5). We found that the majority of those Apj −/− embryos surviving to these stages appeared grossly normal (Online Figure II) , although a small number of dead Apj −/− embryos were also identified at E12.5 (Table) . Despite the normal appearance, evaluation of their developing vessels demonstrated significantly decreased vascular smooth muscle cell layers surrounding the aortic endothelium, suggesting either delayed or defective vascular smooth muscle cell layer recruitment ( Figure 1C ). Dissection of embryos at E10.5 revealed that ≈19% (6 of 32) of the surviving Apj −/− embryos had cardiac abnormalities, with the most severe mutants exhibiting enlarged and abnormally formed hearts that had not completed looping, with large pericardial effusions (Figure 2A , left and middle). In these embryos, there were no bulboventricular groove and no apparent demarcation of a bulbous cordis, with the outflow tract arising from the common ventricle and showing decreased mesenchymal formation. Formation of the atrioventricular cushion was delayed in all of the surviving Apj −/− embryos evaluated at this stage (Figure 2A , right). Apj −/− embryos surviving to the later stages (E12.5 and E15.5), despite their grossly normal size and appearance, were all found to have myocardial defects, including thinning of the myocardium (in all Apj −/− embryos evaluated) and a high prevalence of ventricular septal defects (≈20% of Apj −/− embryos; Figure 2B ; Online Figure  III ). We also found significantly decreased proliferating cell nuclear antigen staining in the hearts of E12.5 Apj −/− embryos compared with wild-type littermates ( Figure 2C ). Moreover, we found in E15.5 Apj −/− embryos significantly decreased capillary densities compared with their wild-type littermates ( Figure 2D ). Finally, we also examined the hearts of Apj −/− mice surviving to adulthood. We found a number of various cardiac malformations, including enlarged right ventricles (4 of 10 Apj −/− mice) and ventricular septal defects (2 of 10 Apj −/− mice), which were not seen in wild-type or heterozygous littermates (Online Figure IV ).
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Apelin-APJ Regulates Endothelial MEF2 Activation in a Gα13-Dependent Manner
On the basis of the observed embryonic lethal phenotype of the Apj −/− mice, we sought to investigate the downstream targets of apelin-APJ signaling in cardiovascular development. Previous analyses of Apj expression in developing mouse, xenopus, and zebrafish embryos demonstrated that APJ is expressed predominantly in the endothelial layers of arteries and veins, as well as in the endocardial layer in the hearts, at E9.5 to E10.5. 15, 25, 26 We confirmed by in situ hybridization in E10.5 embryos that the predominant expression of Apj was in the endocardium and ECs (data not shown). We previously demonstrated that apelin-APJ signaling regulates Krüppellike factor 2 (Klf2) transcription. 4, 27 In concurrence with these data, Klf2 expression as detected by in situ hybridization was decreased in the endocardium of the heart and the endothelial layer of the aorta in E10.5 Apj −/− embryos ( Figure 3A and 3B). Given the extent of evidence demonstrating the role of the MEF2 family of transcription factors regulating KLF2 transcription, [28] [29] [30] we addressed the hypothesis that apelin-APJ signaling induces MEF2 activation. We evaluated the effect of apelin-APJ on 3 MEF2 responsive luciferase constructs: (1) MEF2 luciferase reporter containing 3 tandem MEF2 binding sites (3X-MEF2); (2) a 221-bp promoter region of the KLF2 gene 31 ; and (3) a shorter, 41-bp promoter construct containing the minimal MEF2 binding site from the KLF2 promoter as previously described (Online Figure V) . 30 We found that overexpression of MEF2A and MEF2C in COS7 cells resulted in a robust induction of the 3X-MEF2 luciferase reporter ( Figure 3C ). Overexpression of apelin and APJ in this context resulted in a greater induction of the 3X-MEF2 luciferase reporter activity ( Figure 3C ). Furthermore, overexpression of apelin and APJ in HUVECs induced luciferase reporter activity from all 3 MEF2 reporter constructs, including 2 derived from the KLF2 promoter ( Figure 3D and 3E; Online Figure VI ). APJ transfection alone was also able to significantly induce the 221bp KLF2 promoter ( Figure 3D ). In addition, either mutagenesis of the MEF2 binding site or concurrent knockdown of MEF2A/C with apelin-APJ-transfection resulted in abrogation of apelin-APJ induced MEF2 luciferase reporter activity ( Figure 3D ). To further assess whether apelin-APJ signaling can regulate MEF2 binding on the KLF2 promoter, we conducted chromatin immunoprecipitation assays. The level of MEF2 binding to the KLF2 promoter in HUVECs was markedly decreased by apelin-APJ knockdown ( Figure 3F ). APJ has previously been found to signal through 2 G proteins, namely Gαq and Gαi. 13, 32 To evaluate whether apelin-APJ-mediated induction of MEF2 activity involves either of these G proteins, we overexpressed constitutively active forms of Gαq (Gαq-QL) and Gαi (Gαi-QL) with MEF2A, MEF2C, and the MEF2 luciferase reporter. We found no induction of the MEF2 reporter activity, suggesting that these G proteins were not involved in regulation of MEF2 activity ( Figure 3C ). Gα13, another member of the G protein family, has recently been described to target MEF2 but has not previously been associated with apelin-APJ signaling. 33 We found that constitutively active Gα13 can robustly induce MEF2 activity on the basis of all of the luciferase reporters tested in both COS7 cells ( Figure 3C ) and HUVECs ( Figure 3E ; Online Figure VI) . We next evaluated whether Gα13 is a bona fide target of apelin-APJ signaling. Overexpression of APJ in COS7 cells was able to induce Gα13 activity as measured by guanosine-5'-triphosphate-γS bound-Gα13, which was further augmented by stimulation with the apelin 13 peptide ( Figure 3G ). Moreover, stimulation of HUVECs with apelin 13 led to a robust increase in Gα13 activity, as assessed by immunoprecipitation of GTP-bound Gα13 ( Figure 3H ). Finally, transfection of HUVECs with increasing concentrations of APJ expression plasmid also led to increased Gα13 activity, suggesting an apelin-independent ability of APJ to activate Gα13 ( Figure 3I ).
Apelin-APJ Activates MEF2 Activity Via Phosphorylation and Nuclear Export of HDAC4 and HDAC5 in ECs
MEF2 is known to be regulated by multiple mechanisms, including class II HDAC-mediated inhibition. 34 We next evaluated whether apelin-APJ signaling-mediated regulation of MEF2 activity involves HDACs. Stimulation of HUVECs with apelin 13 led to a robust induction of HDAC4 and HDAC5 translocation to the cytoplasm from the nucleus ( Figure 4A ; Online Figure VII) . Moreover, overexpression of APJ alone in HUVECs also induced translocation of HDAC4 and HDAC5 to the cytoplasm ( Figure 4B ).
In conjunction with the regulation of HDAC4/5 cellular localization, apelin and APJ overexpression in HUVECs resulted in a robust increase in HDAC4 and HDAC5 phosphorylation, which is known to be a critical step leading to their nuclear export ( Figure 4C ). 35 Apelin 13 stimulation was able to induce phosphorylation of HDAC4 and HDAC5 in HUVECs, which was abrogated in the context of small interfering RNA-mediated APJ knockdown ( Figure 4D ). Moreover, APJ knockdown led to decreased HDAC4/5 phosphorylation at baseline. We further validated the role of Gα13 in this signaling cascade by demonstrating that knockdown of Gα13 in HUVECs abrogated the increased HDAC4/HDAC5 phosphorylation in response to APJ overexpression ( Figure 4E ). Moreover, concurrent overexpression of HDAC4 or HDAC5 with apelin and APJ in HUVECs led to inhibition of MEF2 transcriptional activity on the KLF2 promoter-driven luciferase reporter ( Figure 4F ). 
Increased Nuclear Localization of HDAC4 and HDAC5 in Apj −/− Endocardium and ECs
To further validate our in vitro signaling mechanism in our mouse model, we evaluated the localization of Hdac4 and Hdac5 in the Apj −/− embryos. We found that the endocardial cells of E10.5 Apj −/− embryos had a significantly higher percentage of cells with positive nuclear staining for Hdac4 and Hdac5 compared with wild-type littermates ( Figure 5A ).
We also evaluated the isolated heart ECs of Apj −/− mice. We found in ECs isolated from wild-type mice a robust cytoplasmic translocation of both Hdac4 and Hdac5 in response to apelin 13 stimulation ( Figure 5B ). However, in ECs isolated from Apj −/− hearts, we found that the percentage of ECs without nuclear Hdac4 and Hdac5 staining was significantly reduced at baseline and was not affected by apelin 13 stimulation. Moreover, we found decreased levels of phosphorylated Hdac4 and Hdac5 in heart ECs from Apj −/− mice compared with their wild-type littermates ( Figure 5C ).
Shared Transcriptional Targets of Apelin-APJ, Gα13, and MEF2 Are Decreased in Apj −/− Embryos and ECs
Given the preferential endothelial/endocardial expression of Apj in the developing embryo, we further pursued the endothelium-based relationship between apelin-APJ, Gα13, and MEF2 by conducting microarray analyses using HUVECs subjected to following knockdown conditions: (1) apelin and APJ, (2) Gα13, and (3) MEF2A and MEF2C (Online Figure VIII ; GEO accession number GSE46825). We found a large number of genes that were similarly regulated in the 3 conditions, including a number of genes with known roles in cardiovascular development (Online Table I ). We validated a subset of the downregulated genes by qPCR analyses (Figure 6A ; Online Table II ). We found that knockdown of APJ alone (without apelin) also resulted in decreased expression of these targets, although some transcripts were only minimally reduced ( Figure 6A ). To evaluate whether these downregulated genes were also similarly regulated in the Apj −/− mice, we conducted qPCR analyses of E10.5 Apj −/− embryos. The genes confirmed by qPCR analyses in HUVECs, including connexin 37 (CX37), connexin 40 (CX40), and vascular cell adhesion molecule-1, were also significantly downregulated in the Apj −/− embryos ( Figure 6B ). Moreover, we conducted additional qPCR assays in isolated heart ECs from wild-type and Apj −/− mice and found that the majority of these genes were also significantly downregulated ( Figure 6C ). With respect to Klf2, we found in isolated heart ECs no difference in the baseline expression, likely because of the low basal level of expression in mature heart ECs that was detected; however, when these cells were stimulated with rosuvastatin (member Green fluorescent protein is shown in green; FLAG staining is shown in red; and DAPI nuclear staining is shown in blue. The percentage of cells with cytoplasmic HDAC4/5 is shown. ***P<0.001. C, Overexpression of apelin and APJ in HUVECs leads to an increase in HDAC4 and HDAC5 phosphorylation. D, Stimulation of HUVECs with apelin 13 leads to increased HDAC4 and HDAC5 phosphorylation, which is abrogated by APJ knockdown. E, Overexpression of APJ in HUVECs leads to increased phosphorylation of HDAC4 and HDAC5, which is decreased with concurrent Gα13 knockdown. F, Concurrent overexpression of HDAC4 or HDAC5 with apelin-APJ leads to abrogation of apelin-APJ-induced activation of the KLF2-41bp luciferase reporter in HUVECs. ***P<0.001 vs all other conditions. of HMG-CoA reductase inhibitor class of drugs, which are known to induce endothelial KLF2 expression), 31, 36, 37 ECs from wild-type mice demonstrated a significant induction of Klf2, whereas ECs from Apj −/− mice failed to respond in a similar manner ( Figure 6D ).
To further validate these data, we evaluated the protein expression of 2 putative targets of this signaling axis: CX37 and CX40. HUVECs subjected to APJ knockdown expressed decreased levels of CX37 and CX40 as detected by Western blots (Figure 6E ). Moreover, expression of Cx37 and Cx40 was decreased in the aortic endothelium of the E10.5 Apj −/− embryos ( Figure 6F ). We also found reduced expression of Cx37 and Cx40 in isolated heart ECs from Apj −/− mice compared with wild-type littermates ( Figure 6G ).
Discussion
Here, we provide the first description of the cardiovascular developmental defects in Apj −/− mouse embryos. We identified a novel endothelial signaling cascade that originates from apelin-APJ and targets Gα13, resulting in HDAC4/5 cytoplasmic translocation and MEF2 activation. We validate this pathway in vivo by demonstrating increased nuclear localization of Hdac4 and Hdac5 and decreased expression of Klf2, a validated MEF2 target, in Apj −/− embryos. Moreover, we report a number of novel, putative endothelial MEF2 targets, including CX37 and CX40, that will require further investigation. Given the known critical roles of Gα13 and MEF2 in embryonic cardiovascular development, [22] [23] [24] 38, 39 our present findings provide further insights into the upstream signaling mechanism that regulates the activation of these intracellular signaling components in cardiovascular development.
There is considerable evidence for related and overlapping compensatory pathways that account for a number of features of the phenotype of Apj −/− animals in both zebrafish and mouse. The variable penetrance of embryonic lethality in the Apj −/− mice is not unlike what has been described for other G proteincoupled receptor knockout mice, including the Par1 knockout mice 40 and the Cxcr7 knockout mice, 41, 42 and suggest the possibility of alternative G protein-coupled receptor signaling cascades compensating for the loss of apelin-APJ signaling. A nitrosourea-induced inactivating single-base-pair loss-offunction mutation in zebrafish agtrl1b, the grinch mutant, was found to exhibit the severe loss of function phenotype in only half their offspring. 18 This finding is similar to the incomplete loss of embryos in the homozygous Apj −/− mouse model described here. Moreover, the zebrafish mutant phenotype was found to be a function of the genetic background, because different pairs of mutant carriers reproducibly yielded embryos with differing severities of phenotype. There are also anecdotal reports that the embryonic lethality of Apj −/− mice is most severe when examined on specific inbred backgrounds. The observed incomplete penetrance is likely a result of stochastic activation of related pathways, which rescues heart and vascular development, and the observed alteration of this ratio by genetic background likely reflects differences in the ability of the compensatory pathways to be activated when apelin-APJ signaling is absent.
Our findings also suggest that both MEF2A and MEF2C are likely involved in apelin-APJ signaling on the basis of our mechanistic data and the variable phenotype of the Apj −/− mice, some of which mimic the early embryonic lethality of the Mef2c null embryos (Figures 1A, 1B, and 2A) 22, 24 with others sharing the phenotype of the Mef2a null mice (Online Figure IV) . 23 Three Apln −/− mouse lines have been generated and reported in the literature. 16, 43, 44 In each case, the Apln −/− mice were found to be viable with Mendelian inheritance of the null allele. Because apelin is considered to be the only ligand for APJ and APJ to be the only receptor for apelin, the expectation is that the phenotype generated by functional deletion of the Apln and Apj genes should be very similar, if not identical. The likely explanation for differences in the Apln versus Apj null mice is that either a secondary ligand for APJ may exist, or a ligand-independent activation of APJ such as that recently described 1 may be contributing to the developmental context. Indeed, our findings suggest that induction of APJ alone, independently of apelin, may be capable of transducing the signals necessary for MEF2 activation. These findings will require additional investigation to delineate the role of apelindependent and apelin-independent signaling cascades that are downstream of the APJ receptor.
On the basis of the predominance of Apj expression in the endothelium and endocardium of the developing mouse embryos, 25 we chose to focus on the downstream targets of apelin-APJ signaling in the ECs and identified MEF2 as a targeted transcription factor. Our work leaves open the possibility that apelin-APJ signaling in other cell types may also be important for proper cardiovascular development, especially in light of recent findings demonstrating the role of APJ signaling in myocardial progenitor cells in zebrafish. 18, 19, 45 Conditional, tissue-specific Apj-deficient mice are currently being generated and will help address these unresolved questions. Moreover, the role of apelin-independent activation of APJ in the context of cardiovascular development remains to be fully elucidated.
Our previous work had demonstrated that surviving adult Apj −/− mice have a functional cardiovascular defect, and noninvasive imagining studies and isolated cardiomyocyte studies have shown that this is attributable, at least in part, to a primary defect in cardiac contraction. 13, 21 The presence of apelin in tissue and blood likely has a tonic effect on contractile function in adult mice. 13, 46 However, our findings also suggest the possibility of congenital structural defects in some adult Apj −/− mice that further impair their cardiovascular function. We have seen enlarged right ventricles and ventricular septal defects in adult Apj −/− mice that could be contributing to the impaired exercise tolerance of these mice. These congenital defects are in keeping with types of developmental defects identified in the Apj −/− embryos and likely represent survival of those animals with the less severe defects. These observations prompt human studies investigating the association of genetic variation in the APLN and APJ loci with congenital heart abnormalities.
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